These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9974375)

  • 21. Plasma glycoprotein V levels in the general population: normal distribution, associated parameters and implications for clinical studies.
    Aleil B; Meyer N; Wolff V; Kientz D; Wiesel ML; Gachet C; Cazenave JP; Lanza F
    Thromb Haemost; 2006 Oct; 96(4):505-11. PubMed ID: 17003930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of blood coagulation by soluble fibrin complexes.
    Hansen MS; Bang NU; Barton RD; Mattler LE
    J Exp Med; 1975 May; 141(5):944-61. PubMed ID: 805207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism.
    Kamikura Y; Wada H; Nobori T; Kobayashi T; Sase T; Nishikawa M; Ishikura K; Yamada N; Abe Y; Nishioka J; Nakano T; Shiku H
    Thromb Res; 2005; 116(4):307-12. PubMed ID: 16038715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of autoantibodies against fibrinogen and fibrin degradation products by enzyme-linked immunoassay.
    Whitaker AN; McFarlane JR; Rowe EA; Lee K; Masci PP
    Thromb Haemost; 1985 Feb; 53(1):80-5. PubMed ID: 3992524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.
    McCarron BI; Marder VJ; Francis CW
    Thromb Haemost; 1999 Dec; 82(6):1722-9. PubMed ID: 10613661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism. ANTELOPE-Study Group.
    Mac Gillavry MR; Sanson BJ; de Monyé W; Lijmer JG; Huisman MV; Büller HR; Nieuwenhuizen W; Brandjes DP
    Thromb Haemost; 2000 Sep; 84(3):474-7. PubMed ID: 11019974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasma D-dimer levels in patients with deep vein thrombosis].
    Watanabe R; Wada H; Mori Y; Nakasaki T; Sawa H; Shiku H
    Rinsho Byori; 1999 Sep; 47(9):887-90. PubMed ID: 10518428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What role does the measurement of fibrinogen and its derivatives have in the diagnosis of disseminated intravascular coagulation?
    Dempfle CE
    Blood Rev; 2002 Dec; 16 Suppl 1():S23-8. PubMed ID: 12918784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative determination of fibrin and fibrinogen in biological material.
    Haeberli A; Straub PW
    J Lab Clin Med; 1980 Aug; 96(2):258-66. PubMed ID: 6447180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
    Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.
    Curtin N; Highe G; Harris M; Braunstein A; Demattia F; Coss L
    Lab Hematol; 2004; 10(2):88-94. PubMed ID: 15224764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.
    Dempfle CE; Zips S; Ergül H; Heene DL;
    Thromb Haemost; 2001 Apr; 85(4):671-8. PubMed ID: 11341504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inability of serial fibrin monomer measurements to predict or exclude deep venous thrombosis in asymptomatic patients undergoing total knee arthroplasty.
    Reber G; Blanchard J; Bounameaux H; Hoffmeyer P; Miron MJ; Leyvraz PF; de Moerloose P
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):305-8. PubMed ID: 10870811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of a D-dimer rapid-test with a plasma-immunoassay for diagnosis of venous thrombosis or pulmonary embolism in a medical emergency unit].
    Stey C; Steurer J; Fehr J
    Praxis (Bern 1994); 1999 Mar; 88(11):463-70. PubMed ID: 10218425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid and quantitative D-Dimer assay in whole blood and plasma on the point-of-care PATHFAST analyzer.
    Fukuda T; Kasai H; Kusano T; Shimazu C; Kawasugi K; Miyazawa Y
    Thromb Res; 2007; 120(5):695-701. PubMed ID: 17316774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fibrinogen antigenic turbidimetric assay (FIATA): the X2x test--the corrected chi-square comparison against the control-mean.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):73-100. PubMed ID: 17164498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A soluble fibrin standard: comparable dose-response with immunologic and functional assays.
    McCarron BI; Marder VJ; Kanouse JJ; Francis CW
    Thromb Haemost; 1999 Jul; 82(1):145-8. PubMed ID: 10456469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
    Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
    Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
    Sallah S; Wan JY; Nguyen NP
    Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.